As diagnostic laboratories expand, a basic CBC counter often becomes a limiting factor. Rising sample volumes, more complex clinical demands, and tighter budgets force lab managers to ask whether a single-purpose hematology analyzer is still sufficient.

The EHBT‑50 multi-functional analyzer is designed to answer that question by integrating AI-enhanced complete blood morphology (CBM), immunoassay, and dry biochemistry into one compact, maintenance-free system. For growing labs looking to move beyond standalone CBC without filling the bench with multiple devices, the EHBT‑50 offers an all-in-one, AI-driven “mini lab.”

A Digital Diagnostics Platform with Global Reach

The EHBT‑50 is developed by Ozelle, a digital diagnostics company that originated in a Silicon Valley laboratory in 2014 and focuses on applying AI and IoT technologies to medical diagnostics. Over time, Ozelle has installed more than 50,000 units worldwide and processed over 40 million samples across its platforms, supported by a monthly production capacity above 5,000 units.

Global R&D and manufacturing centers span Frankfurt, Abu Dhabi, Shenzhen, and Changsha, covering more than 8,700 m² of dedicated facilities. The organization reports over 500 employees, with more than 60% engaged in R&D, and holds more than 500 technology patents in AI diagnostics, optical systems, and smart detection algorithms. Certifications such as FDA, CE, ISO 9001 and ISO 13485:2016 further support the EHBT‑50 as a professionally validated device.

For a growing diagnostic lab, this context means the EHBT‑50 sits within a mature ecosystem rather than being an isolated instrument.

Why Growing Labs Need More Than a Basic CBC Counter

The evolution of CBC technology shows a clear trend: from manual microscopy in the 19th century to impedance methods in the 1950s, flow cytometry in the 1970s, and AI plus cell morphology in the modern era. Many basic CBC counters still rely on limited differentials, manual processes, or minimal morphology support, and they can struggle with:

• Manual operation and non-standardized workflows.
• Lower bio-safety due to open reagents and waste handling.
• Limited automation and throughput.
• Minimal integration with other test types.

The CBM concept (CBC plus smear-like morphology) aims to overcome these issues by providing fully automatic analysis, standardized pretreatment and testing, integrated analysis, sealed cartridges for improved safety, and efficient one-key operation with around six minutes per sample. For growing labs, CBM offers a pathway to richer data and higher efficiency without reverting to manual smear review for every case.

EHBT‑50: A Multi-Functional Mini Lab

The EHBT‑50 is engineered as a multi-functional analyzer that unifies three major testing domains on one instrument:

• CBM using AI-based cell morphology.
• Immunoassay using fluorescence immunochromatographic analysis.
• Dry biochemical analysis for key clinical chemistry panels.

It handles whole blood and capillary blood, using approximately 100 μL for whole blood and 30 μL for capillary samples. Single-serving reagent cards can be stored at room temperature for up to two years, easing inventory management. The analyzer provides a 10.1‑inch touch screen interface and integrates both internal and external printing options. With dimensions around 400 mm × 350 mm × 450 mm and a weight of about 15 kg, it fits comfortably into most lab layouts.

For a lab deciding whether to buy a separate CBC analyzer, immunoassay platform, and chemistry analyzer, the EHBT‑50 offers an alternative: one unified device for all three.

AI Cell Morphology at the Core of CBM

At the heart of the EHBT‑50 is an AI-powered CBM engine. This engine uses:

• An AI model trained on a dataset exceeding 40 million blood cell images, recognized at a major AI conference.
• A Swiss Optical customized lens delivering 4M resolution with a frame rate of 50 fps.
• Mechanical positioning accuracy under 1 μm to ensure stable, repeatable imaging.

The system can identify a wide range of cell types and abnormalities, including:

• RBC morphology: schistocytes, echinocytes, reticulocytes, teardrop cells.
• WBC populations: neutrophils, lymphocytes, monocytes, eosinophils, basophils, plus segmented, stab, and hypersegmented neutrophils.
• Platelets and platelet aggregates.

This imaging-based approach allows the EHBT‑50 to capture morphology that basic CBC counters cannot, helping labs detect subtle changes earlier and with greater consistency.

Image-Based AI vs Traditional CBC Methods

The EHBT‑50’s image-based AI is positioned as a complement to traditional CBC methods rather than a replacement.

• Manual microscopy offers detailed morphology but is slow and heavily dependent on individual expertise.
• Electrical impedance focuses on cell volume and count, with limited morphology and no visual images.
• Flow cytometry offers high throughput and uses fluorescence-based markers, but requires complex pre-processing and still does not generate direct cell images.
• Image-based AI, as used by the EHBT‑50, relies on cell morphology, provides high-resolution features for AI recognition, supports full automation, and generates fully visual images that can be reviewed.

The key message is “not to replace, but to empower diagnostic,” making AI a partner for human experts by providing consistent, automated morphology interpretation that still allows visual verification.

Cobertura exaustiva de parâmetros

One of the major advantages of the EHBT‑50 is its rich parameter menu across hematology, immunoassay, and chemistry.

Hematology and CBM Parameters

Hematology output includes:

• RBC/HGB: RBC, HGB, HCT, MCV, MCH, MCHC, RDW‑CV, RDW‑SD, RET# and RET%.
• Platelets: PLT, MPV, PDW, PCT, PAg, P_LCC, P_LCR.
• WBC and differentials: WBC, NEU#, NEU%, NST#, NST%, NSG#, NSG%, NSH#, NSH%, LYM#, LYM%, MON#, MON%, EOS#, EOS%, BAS#, BAS%, ALY, NLR.

These parameters provide a full 7‑diff profile plus reticulocyte and platelet indices, supported by morphology flags and images.

Immunoassay Parameters

The immunoassay module supports parameters such as:

• Inflammation and acute-phase markers: CRP, combined CRP/SAA, PCT, IL‑6, SAA-related combinations.
• Cardiac markers: NT‑proBNP, cTnI, CK‑MB.
• Endocrine and metabolic markers: T3, T4, TSH, HbA1c, vitamin D (VD).
• Coagulation and fibrinolysis-related markers such as D‑dimer.

This allows labs to run key inflammatory, cardiac, and endocrine tests on the same platform as hematology.

Dry Chemistry Panels

Dry biochemistry panels include combinations such as:

• ALT/AST/UA/CR for liver and renal function.
• Glucose with UA/TC/TG for metabolic assessment.
• Panels combining ALT, AST, ALB, and TB or UA, CR, and UREA for more comprehensive organ function evaluation.

Together, these chemistry options cover core tests needed in many small and mid-sized labs.

Automation, Wet-Staining, and Optical Quality

The EHBT‑50’s design focuses on automation and optical precision for all its test modes.

• A fully automated mechanical arm achieves repeatable positioning with sub‑micron accuracy.
• High-resolution imaging and high-speed acquisition ensure sharp, consistent cell images.
• Wet-staining technology based on Wright–Giemsa staining improves cell classification, especially for neutrophils and RBC morphology.

Comparisons between traditional staining and the EHBT‑50’s images show enhanced clarity and contrast, which in turn supports both AI classification and human review.

Efficiency and Cost Control for Growing Labs

Efficiency is critical when a single device handles CBC, immunoassay, and chemistry. The EHBT‑50 addresses this by:

• Processing samples in approximately 6 minutes per run.
• Supporting four test modes to flexibly combine hematology, immunoassay, and biochemistry.
• Requiring low sample volumes (around 30 μL capillary or 100 μL EDTA).

The all-in-one disposable cartridge structure minimizes additional consumables, with hematology cartridges offering up to 2 years of room-temperature shelf life and immunoassay/biochemistry components about 18 months. The system emphasizes low cost with real benefits, including room-temperature transportation and a design that requires no routine maintenance. For growing labs, this simplifies logistics and reduces total cost of ownership compared to maintaining multiple analyzers.

Test Kits and Fluorescence Components

To streamline operations, the EHBT‑50 comes with dedicated test kits that include:

• Combined reagent kit.
• Sample tube.
• Disposable capillary blood collection tube.
• Counting chamber.
• Tips.

Fluorescence components—such as fluorescence test cards and diluents—support the immunoassay functions. Consolidating everything into organized kits reduces setup errors and simplifies daily workflows.

User-Friendly Workflow and Minimal Training

The EHBT‑50 is designed to be easy for technologists to learn and operate.

• Graphic buttons and quick review functions make navigation straightforward.
• A smart built-in camera automatically checks correct placement of consumables.
• No sample pre-treatment is required, minimizing manual preparation steps.
• Minimal installation and training costs, thanks to a liquid-free design with a low fault rate and no maintenance needs.

The interface guides users through CBC testing and analysis, while similar workflows apply to immunoassay and biochemistry, ensuring a consistent user experience across all test types.

Smart Diagnosis and IoT-Ready Management

The EHBT‑50 integrates into a broader digital ecosystem that supports smart diagnosis and device management.

A patient management application lists orders, tracks status, and links to AI reports, helping clinicians follow up on CBC, immunoassay, and chemistry testing. AI-generated “possible basis for diagnosis and inference” sections highlight patterns associated with bacterial infections, viral infections, and autoimmune diseases, while stressing that these suggestions are for reference only.

On the operations side, an IoT-based platform allows remote device monitoring, batch label management, and control functions such as restarting devices. Additional platforms manage operations data, equipment and consumables, and sample analysis workflows. For growing labs, this digital layer simplifies scaling and ensures that multiple EHBT‑50 units can be centrally managed.

Why Choose EHBT‑50 Over Separate Instruments

For a laboratory upgrading from a basic CBC counter, the key question is whether to invest in several specialized devices or one multi-functional analyzer. The EHBT‑50 offers:

• AI-enhanced CBM with a full set of hematology parameters and morphology images.
• Integrated immunoassay for inflammation, cardiac, endocrine, and related markers.
• Dry chemistry for core liver, kidney, and metabolic panels.
• Maintenance-free, cartridge-based operation with room-temperature storage.
• Efficient throughput at about 6 minutes per sample.
• Low sample volume requirements and a compact footprint.
• User-friendly workflows with minimal training and no sample pre-treatment.
• Integration into an AI and IoT ecosystem for smart diagnosis and fleet management.

For growing labs, this unified approach can streamline workflows, expand test offerings, and reduce overall costs compared to installing and maintaining multiple separate analyzers.

For more details about this multi-functional hematology analyzer, you can visit the official product page: https://ozellemed.com/en/ehbt-50/.